Form 4 Filing for IRADIMED CORP

Roger E. Susi, CEO, President, and Chairman of IRADIMED CORP, reported the sale of Common Stock through multiple transactions on April 6th and 7th, 2026. These sales were executed under a Rule 10b5-1 trading plan. On April 6th, Mr. Susi sold a total of 5,400 shares at a weighted average price of $95.21, $96.24, and $96.78. On April 7th, he sold an additional 2,500 shares at weighted average prices of $94.36 and $95.58. Following these transactions, the post-transaction shares owned by Phillip Susi 2008 Dynasty Trust were 2,217,500. The filing also notes holdings in the Roger E. Susi Revocable Trust (162,950 shares) and the Matthew Susi 2008 Dynasty Trust (2,062,500 shares). Mr. Susi disclaims beneficial ownership of the shares held in the Matthew Susi 2008 Dynasty Trust except to the extent of his pecuniary interest.